19-4361606-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_003025.4(SH3GL1):c.1101G>A(p.Pro367Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00625 in 1,595,932 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0044 ( 3 hom., cov: 33)
Exomes 𝑓: 0.0064 ( 41 hom. )
Consequence
SH3GL1
NM_003025.4 synonymous
NM_003025.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.83
Genes affected
SH3GL1 (HGNC:10830): (SH3 domain containing GRB2 like 1, endophilin A2) This gene encodes a member of the endophilin family of Src homology 3 domain-containing proteins. The encoded protein is involved in endocytosis and may also play a role in the cell cycle. Overexpression of this gene may play a role in leukemogenesis, and the encoded protein has been implicated in acute myeloid leukemia as a fusion partner of the myeloid-lymphoid leukemia protein. Pseudogenes of this gene are located on the long arm of chromosomes 11 and 17. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 19-4361606-C-T is Benign according to our data. Variant chr19-4361606-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3067189.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-2.83 with no splicing effect.
BS2
High AC in GnomAd4 at 676 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH3GL1 | NM_003025.4 | c.1101G>A | p.Pro367Pro | synonymous_variant | 10/10 | ENST00000269886.7 | NP_003016.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH3GL1 | ENST00000269886.7 | c.1101G>A | p.Pro367Pro | synonymous_variant | 10/10 | 1 | NM_003025.4 | ENSP00000269886.2 | ||
SH3GL1 | ENST00000417295.6 | c.957G>A | p.Pro319Pro | synonymous_variant | 9/9 | 2 | ENSP00000404568.2 | |||
SH3GL1 | ENST00000598564.5 | c.909G>A | p.Pro303Pro | synonymous_variant | 10/10 | 2 | ENSP00000470792.1 |
Frequencies
GnomAD3 genomes AF: 0.00444 AC: 676AN: 152110Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
676
AN:
152110
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00390 AC: 922AN: 236624Hom.: 6 AF XY: 0.00395 AC XY: 510AN XY: 128984
GnomAD3 exomes
AF:
AC:
922
AN:
236624
Hom.:
AF XY:
AC XY:
510
AN XY:
128984
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00644 AC: 9296AN: 1443706Hom.: 41 Cov.: 31 AF XY: 0.00623 AC XY: 4474AN XY: 717902
GnomAD4 exome
AF:
AC:
9296
AN:
1443706
Hom.:
Cov.:
31
AF XY:
AC XY:
4474
AN XY:
717902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00444 AC: 676AN: 152226Hom.: 3 Cov.: 33 AF XY: 0.00415 AC XY: 309AN XY: 74434
GnomAD4 genome
AF:
AC:
676
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
309
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 11, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | SH3GL1: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at